CA Patent

CA2440387A1 — Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space

Assigned to Durect Corp · Expires 2002-10-03 · 24y expired

What this patent protects

The present invention provides delivery of drugs to the heart or cardiac vasculature using fully implanted sustained-release dosage forms.

USPTO Abstract

The present invention provides delivery of drugs to the heart or cardiac vasculature using fully implanted sustained-release dosage forms.

Drugs covered by this patent

Patent Metadata

Patent number
CA2440387A1
Jurisdiction
CA
Classification
—
Expires
2002-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Durect Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.